0000950170-23-025368.txt : 20230531 0000950170-23-025368.hdr.sgml : 20230531 20230531163632 ACCESSION NUMBER: 0000950170-23-025368 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230526 FILED AS OF DATE: 20230531 DATE AS OF CHANGE: 20230531 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Brownstein Carrie CENTRAL INDEX KEY: 0001894232 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39593 FILM NUMBER: 23981529 MAIL ADDRESS: STREET 1: 500 W. 5TH ST. STREET 2: SUITE 1200 CITY: AUSTIN STATE: TX ZIP: 78701 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Shattuck Labs, Inc. CENTRAL INDEX KEY: 0001680367 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 812575858 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 500 W. 5TH STREET CITY: AUSTIN STATE: TX ZIP: 78701 BUSINESS PHONE: 512-900-4690 MAIL ADDRESS: STREET 1: 500 W. 5TH STREET CITY: AUSTIN STATE: TX ZIP: 78701 4 1 ownership.xml 4 X0407 4 2023-05-26 0001680367 Shattuck Labs, Inc. STTK 0001894232 Brownstein Carrie C/O SHATTUCK LABS, INC. 500 W. 5TH STREET, SUITE 1200 AUSTIN TX 78701 true false false false false Stock Option (Right to Buy) 2.72 2023-05-26 4 A false 40258 0.00 A 2033-05-26 Common Stock 40258 40258 D This option represents the right to purchase a total of 40,258 shares of the Issuer's common stock, which will vest in full on the earlier of the one-year anniversary of the grant date or immediately prior to the Issuer's next annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer. /s/ Andrew R. Neill, Attorney-in-Fact for Carrie Brownstein 2023-05-31